<DOC>
	<DOCNO>NCT02227927</DOCNO>
	<brief_summary>Domperidone drug may benefit individual gastroesophageal reflux disease ( GERD ) , upper GI symptom , gastroparesis , chronic constipation . This long-term treatment program prescription drug patient , investigator ' judgement , could benefit use .</brief_summary>
	<brief_title>Treatment Use Domperidone Gastroparesis</brief_title>
	<detailed_description>The Treatment Use Domperidone program also available Cleveland Clinic Florida/Weston Gastroenterology Department . This `` traditional '' research study , expand use protocol patient may benefit drug . As , expense associate drug , initiation follow treatment responsiblity patient patient 's third party payor .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>Male female Age 18 old Symptoms manifestation secondary GERD ( e.g. , persistent esophagitis , heartburn , upper airway sign symptom respiratory symptom ) , gastrointestinal motility disorder nausea , vomit , severe dyspepsia severe chronic constipation refractory standard therapy . Patients must comprehensive evaluation eliminate cause symptom . Patient sign informed consent administration domperidone inform patient potential adverse event include : increase prolactin level extrapyramidal side effect breast change cardiac arrhythmia include QT prolongation death There potential increase risk adverse event drug list domperidone protocol addendum . History , current , arrhythmias include ventricular tachycardia , ventricular fibrillation Torsade des Pointes . Patients minor form ectopy ( PACs ) necessarily exclude . Clinically significant bradycardia , sinus node dysfunction , heart block . Prolonged QTc ( QTc &gt; 450 millisecond male , QTc &gt; 470 millisecond female ) . Clinically significant electrolyte disorder . Gastrointestinal hemorrhage obstruction Presence prolactinoma ( prolactinreleasing pituitary tumor ) . Pregnant breast feed female Known allergy domperidone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Gastroesophageal Reflux Disease</keyword>
	<keyword>GERD</keyword>
	<keyword>Gastroparesis</keyword>
	<keyword>Domperidone</keyword>
</DOC>